ExploreWatchlistsPricing
  1. JP-listed companies
  2. ROHTO PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Repayments of term debt

ROHTO PHARMACEUTICAL CO.,LTD. (4527)

Market cap
¥565.1B
P/E ratio
16.4x
Rohto Pharmaceutical manufactures and sells eye care, skin care, and oral medications globally through its subsidiaries including Mentholatum brands.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndRepayments of term debt (Million JPY)YoY (%)
Mar 31, 2025-5,961+71.10%
Mar 31, 2024-3,484-60.23%
Mar 31, 2023-8,761+179.64%
Mar 31, 2022-3,133+66.65%
Mar 31, 2021-1,880+163.31%
Mar 31, 2020-714+10.53%
Mar 31, 2019-646+93.99%
Mar 31, 2018-333-50.88%
Mar 31, 2017-678-43.03%
Mar 31, 2016-1,190-7.03%
Mar 31, 2015-1,280

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat